Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Bioconjug Chem. 2009 Dec;20(12):2199–2213. doi: 10.1021/bc900167c

Figure 1.

Figure 1

Schematic presentation of the radiotracer design. The targeting biomolecule is a multimeric cyclic RGD peptide. The PKM linker is used to modify radiotracer pharmacokinetics. For the metal-containing radiotracers, a multidentate BFC is often used to attach the metallic radionuclide to the targeting biomolecule. For 18F-based radiotracers, an organic precursor or synthon is often needed to attach 18F onto the multimeric cyclic RGD peptide.